Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Rev Clin Gerontol. 2012 Feb 1;22(1):10–34. doi: 10.1017/s0959259811000190

Obesity in Older Adults: Epidemiology and Implications for Disability and Disease

Rafael Samper-Ternent 1, Soham Al Snih 1,2,3
PMCID: PMC3278274  NIHMSID: NIHMS353046  PMID: 22345902

Summary

Obesity is a worldwide problem with increasing prevalence and incidence in both developed and developing countries. In older adults, excess weight is associated with a higher prevalence of cardiovascular disease, metabolic disease, several important cancers, and numerous other medical conditions. Obesity has been also associated with increased functional limitations, disability, and poorer quality of life. Additionally, obesity has been independently associated with all-cause mortality. The obesity epidemic has important social and economic implications, representing an important source of increased public health care costs. The aim of this review is to report the epidemiology of obesity world-wide and the implications of obesity on disability and chronic diseases.

Keywords: Obesity, Older Adults, Disability, Chronic Disease


Obesity is a health concern in both developed and developing countries. Numerous studies have documented an increase in the prevalence of obesity worldwide, a trend that has been described as an “epidemic”. Increases in the prevalence of obesity have been observed in men and women, in all age groups, in all major ethnic groups, and at all educational levels. According to the World Health Organization (WHO), obesity prevalence has doubled since 1980 1. Some authors argue that up to one third of the life expectancy gains over time attributable to public health achievements, such as reductions in smoking are counteracted by the simultaneous increase in obesity prevalence 2;3. Among older adults, obesity has been related to higher rates of disability and poor overall health 4. This is especially relevant given the expected worldwide growth of older adult populations.

We searched Medline, PubMed, EMBASE and World of Science databases and websites for the World Health Organization, and for major longitudinal studies on ageing such as the English Longitudinal Study on Ageing (ELSA) [http://www.esds.ac.uk/longitudinal/access/elsa/] the Survey of Health, Ageing and Retirement in Europe (SHARE) [http://www.share-project.org/], the Health and Retirement Study (HRS) [http://hrsonline.isr.umich.edu/], The Health, Well-Being, and Ageing Survey (SABE). We did not limit the search by type of study given the complexity of the topics addressed; however, we did limit the search to manuscripts published in core clinical and epidemiological journals between 1991 and 2011, given the focus of the review. Our initial search terms included ‘obesity’, ‘prevalence’, ‘trends’, ‘older adults’ and ‘epidemiology’. We went on to conduct several further searches to find articles related to obesity and disability and obesity and chronic diseases for each of the sub-sections covered in this article.

Epidemiology of Obesity around the World

Comparisons between regions around the world indicate a wide variation in prevalence of obesity. Despite these regional differences, over time the prevalence of obesity has increased worldwide 1. Table 1 summarizes the prevalence of obesity according to studies published in the last two decades using information from three regions in the world: North America (USA and Canada), Latin America and Europe.

Table 1.

Summary of literature review of studies reporting prevalence of obesity around the world in the past two decades.

Author Year Age Inclusion Type of Study BMI cut-off
points
Mean BMI or prevalence Region Notes
MacDonald,
SM14
1997 18 -74 y/o Cross sectional surveys
conducted in ten Canadian
provinces between 1986 -
1992
Obesity
considered
as BMI ≥ 27
Mean BMI for men was 25.8
(SD 4.03) and 24.9 (SD 5.14)
for women. A total of 35% of
men and 27% of women were
considered to be obese.
North America Additional study conducted with
same dataset by the same group
reported no differences in BMI
between urban and rural areas of
Canada
Torrance,
GM13
2002 20 - 69 y/o Cross sectional study using
three different national
surveys to determine trend
in obesity of adults in
Canada.
WHO cut-
points
Prevalence of obesity increased
over time for men from 8.1%
(1970-72) to 12% (1978-79) to
13.4 (1986-1992). Similarly for
women the prevalence
increased from 12.7% (1970-72)
to 14.9% (1978-79) to 15.4
(1986-1992).
North America No differences observed by
education, however smoking
status had a strong relationship
with increasing obesity trends.
Kaplan, MS12 2003 ≥ 65 y/o Cross sectional study using
wave 2 (1996-1997) of the
CNPHS survey
WHO cut-
points
A total of 12.8% of older adults
fell under the obese category
North America Overall, men were 37% more likely
to be obese than women. Obesity
was also more common among
younger senior adults; less
educated; unmarried; nonsmokers;
infrequent and heavier alcohol
users; physically inactive; more
comorbidities; functional
limitations; poorer self-rated
health; and reporting psychological
distress. Place of birth also
predicted obesity.
Crimmins, E7 2005 ≥ 65 y/o Longitudinal WHO cut-
points
Prevalence increased from
21.4% (1988-1994) to 30.8%
(1999-2000)
North America NHANES III and IV data
Ford, ES9 2009 25 to 74 y/o Cross-sectional WHO cut-
points
Age adjusted prevalence of
obesity: 11.1[1971-1975]; 10.9
[1976-1980]; 15.5 [1988-1994];
19.3 [1999-2004]
North America NHANES
Bleich, SN5 2009 ≥ 20 y/o Cross sectional WHO cut-
points
Prevalence of obesity reported
at 22% [1988-1994] and 31%
[1999-2004]
North America NHANES. Examines relationship
between increased consumption of
sugar-sweetened beverages with
increasing prevalence of obesity
Lix, LM16 2009 ≥ 20 y/o Cross sectional study using
2 waves of the CCHS
(2000-2001 and 2005-2006)
WHO cut-
points
At baseline 20% of the
population was obese. Between
baseline and follow up there
was an increase in prevalence
of obesity but only for Aboriginal
participants. Prevalence of
obesity at baseline for
Aboriginals was 20.2% (95% CI
18.1-22.4) and 18.5% (95% CI
15.9-21.0) for Non-Aboriginals.
At follow-up the prevalence was
25.4 %( 95% CI 20.5-30.2) and
21.1 %( 18.3-23.9) for
Aboriginals and Non-Aboriginals
respectively.
North America Cover three regions of northern
Canada. Variations in prevalence
of obesity observed by ethnic
group and region.
Cohen, JD6 2010 20 to 74 y/o Analysis of trend using data
from NHANES I, II and III
WHO cut-
points
Mean BMI for each cross-
section: 25.5(±5.0) [1976-1980];
27.3(±5.9) [1988-1994];
28.7(±6.6) [1999-2006].
Prevalence of obesity for each
cross-section: 15%[1976-1980],
26% [1988-1994] and 34%
[1999-2006].
North America NHANES 1976-2006 data.
Examined trends in serum lipids as
main outcome. Only individuals
with 1 or more total cholesterol or
lipid results were included.
Flegal, KM8 2010 ≥ 20 y/o Analysis of trends using
cross-sectional data from
NHANES between 1999-
2000 and 2007-2008
WHO cut-
points
In 2007-2008 the age adjusted
prevalence of obesity was
33.8% (95% CI 31.6%-63.0%).
For men it was 32.2% (95% CI
29.5-35.0) and for women
35.5% (95% CI 33.2-37.7).
North America Differences observed by gender
and race/ethnicity. Between 1999-
2000 and 2007-2008 a 4.7%
increase in obesity for men and
2.1% increase for women were
observed. Prevalence change for
women was not significant.
Prevalence of overweight and
obesity was 68%.
Stenholm, S11 2010 ≥ 60 y/o Longitudinal study in
Baltimore
WHO cut-
points
Mean BMI for men of three
different cohorts from the BLSA
study: 24.2(±3) [1877-1899];
25.2(±3.2) [1900-1919];
27.5(±4.3) [1920-1943]
North America Secular increase in bodyweight in
three cohorts of older white men in
the US independent of body
height. BLSA study
Ford, ES10 2011 ≥ 20 y/o Analysis of trends using
cross-sectional data
between 1999-2000 and
2007-2008
WHO cut-
points
Age adjust mean BMI for men
26.9 in 1999-2000 and 32% in
2007-2008; In women 33.2% in
1999-2000 and 35.2 in 2007-
2008
North America Analyzes trends in obesity and
abdominal obesity using NHANES
data
Bruce, SG15 2010 ≥ 18 y/o Cross Sectional study using
data from an Aboriginal
group in Canada
WHO cut-
points
A total of 56% of the sample
were obese. A total of 50% of
men and 65% of women were
obese.
North America Analyses one group of Aboriginal.
Aboriginals in Canada are
considered to have poorer overall
health compared to other ethnic
groups in Canada.
Ruiz-Arregui,
L19
2005 ≥ 60 y/o Cross sectional study using
the first wave (2001) of the
MHAS
WHO cut-
points
Obesity was present in 20.9% of
the total population. A total of
24.8% of women and 17.3% of
men were obese.
Latin America Hypertension and limitations in
walking were associated to higher
prevalence of obesity
Monteiro, CA18 2007 ≥ 20 y/o Uses cross sectional data
from 3 national surveys in
Brazil (1975, 1989, 2003) to
estimate trends in Obesity
WHO cut-
points
Mean BMI Men: 22.4 SE 0.08
[1975], 23.5 SE 0.07 [1989],
24.6 SE 0.04 [2003]. Mean BMI
Women: 23.0 SE 0.08 [1975],
24.5 SE 0.07 [1989], 24.7 SE
0.04 [2003]. Prevalence of
obesity was 2.7% in 1975, 5.1%
in 1989 and 8.8% in 2003 for
men and 7.4%, 12.4% and 13%
for women in the same years.
Latin America Obesity trends in men increased
but in women remained the same
between 1989 and 2003 compared
to 1975-1989. Increases in obesity
were more prevalent in lower SES
quintiles for both men and women.
Al Snih, S44 2010 ≥ 65 y/o Cross sectional study using
data from the SABE study
that included 6 cities in Latin
America and the Caribbean
WHO cut-
points,
separates
category I
(BMI
between 30
and 34.9)
from
category II
and extreme
obesity (BMI
≥ 35)
Mean BMI for the different cities:
Bridgetown, Barbados 26.9
(95% CI 26.4-27.3); Sao Paolo,
Brazil 26.4 (95% CI 26.1-26.7);
Santiago, Chile 27.7 (95% CI
27.2-28.2); Havana, Cuba 24.2
(95% CI 23.9-24.5); Mexico
City, Mexico 27.5 (95% CI 27.1-
27.8); Montevideo, Uruguay
28.3 (95% CI 27.9, 28.8). The
prevalence of category I obesity
was: Bridgetown, Barbados
15.2% (95% CI 13.1-17.4); Sao
Paolo, Brazil 17.6 (95% CI 15.5-
19.8); Santiago, Chile 22.9%
(95% CI 20.1-25.8); Havana,
Cuba 10.4% (95% CI 8.4-12.4);
Mexico City, Mexico 21.3%
(95% CI 18.2-24.4);
Montevideo, Uruguay 21.9%
(18.5-25.3). The range for
category II and extreme obesity
was between 2.9% and 15.7%.
Latin America Obesity is an independent factor
contributing to ADL disability.
Category I and Category II obesity
are presented separately. We
added both percentages to report
prevalence of obesity overall.
Morabia, A26 2005 35-74 y/o Cross-sectional yearly
interviews of people in
Switzerland between 1993-
2003
WHO cut-
points
Prevalence of obesity increased
from 9% in 1993 to 15% in 2003
in men; in women it increased
from 7% to 11%.
Europe Age adjusted trends.
Andreyeva, T21 2007 ≥ 50 y/o Cross sectional data study
using data from the first
wave of SHARE (2004) a
panel study including eleven
countries in Europe.
WHO cut-
points
Obesity was present in 16.2% of
men and 17.8% of women. The
prevalence for each country was
as follows: 17.9% in Austria,
14%in Denmark, 15.1% in
France, 16.9% in Germany,
16.8% in Greece, 15.2% in Italy,
13% in the Netherlands, 20.2%
in Spain, 12.8% in Sweden,
13% in Switzerland; for women
the prevalence was: 19.7% in
Austria, 13.3%in Denmark,
15.1% in France, 17.4% in
Germany, 21.9% in Greece,
17.1% in Italy, 16.5% in the
Netherlands, 25.6% in Spain,
14.4% in Sweden, 12.3% in
Switzerland
Europe
Charles, MA22 2008 ≥ 18 y/o Uses cross sectional data
from 4 national surveys in
France (1997, 2000, 2003,
2006) to examine trends in
obesity
WHO cut-
points
Prevalence of obesity increased
from 8.6% (95% CI 8.2-8.8) in
1997 to 13.1% (95% CI 12.7-
13.5) in 2006.
Europe Parallel increase in obesity trends
for men and women between
1997-2003 but slightly lower in
men between 2003-2006.
Lang, IA25 2008 ≥ 65 y/o Longitudinal study using
data from ELSA to predict
mortality and disability by
BMI status
WHO cut-
points
Prevalence of obesity at
baseline was 19.4% for men
and 28.9% for women.
Europe Obesity at baseline was related to
higher risk of mortality and
disability.
Kotseva, K20 2009 <= 70 y/o Cross sectional study using
EUROASPIRE I,II and III
data
WHO cut-
points
Age and diagnosis adjusted:
25% [95-96]; 32.6% [99-00];
38% [06-07]
Europe EUROASPIRE I-III are cross-
sectional studies conducted in
acute hospital in 8 European
countries (Republic, Finland,
France, Germany, Hungary, Italy,
the Netherlands, and Slovenia) to
identify prevalence of
cardiovascular risk factors.
Interviews were conducted in
1995-96, 1999-2000 and 2006-07.
Large variation by country was
observed. Euroaspire studies are
hospital based convenient samples
Dugravot, A23 2010 45-65 y/o Longitudinal WHO cut-
points
Obesity rates for men were
3.4% and 7.7% for managers
and unskilled workers
respectively at age 45 and 9.5%
and 18.1% for managers and
unskilled workers respectively at
age 65. Statistically significant
increases in BMI trajectories in
20 year period for men and
women by education and
occupation category.
Europe Examined socioeconomic
differences in trajectories of BMI
and obesity between age 45 and
65 in France.
Hubbard, RE24 2010 ≥ 65 y/o Cross Sectional study using
wave 2 (2004) of the ELSA
study
WHO cut-
points
Mean BMI for the sample was
27.5 (95% CI 27.4-27.7).
Prevalence of obesity was
29.1% for women and 23.4% in
men.
Europe Analyzed the relationship between
BMI and frailty and examined
differences by Frailty definition
used.
Gomez-
Cabello, A27
2011 ≥ 65 y/o Longitudinal Study in Spain WHO cut-
points
Prevalence of obesity was
40.9% for women and 26.6% for
men, the overall rate was 37.6%
Europe Differences reported using waist
circumference, BMI and body fat.
Banks, J99 2006 55-64 y/o Cross sectional data from
two studies: 2002 HRS in
the US and 2002 ELSA in
the UK
WHO cut-
points
Prevalence is 23.0% for the UK
and 31.1% for the US.
Comparison
between
regions - USA
+ Europe
Significant difference at the .01
level, controlling for income and
education
Michaud, PC28 2007 ≥ 50 y/o Cross sectional data
comparing data from the
HRS (2004) and the first
wave of SHARE (2004)
WHO cut-
points
Obesity was present in 30.7% of
men in the USA and 17.6% in
Europe and 37.9% of women in
USA and 24.2% of women in
Europe. The prevalence of
obesity by European country for
men was: 19.8% in Austria,
18.6% in Germany, 15.8% in
Sweden, 15.3% in the
Netherlands, 20.8% in Spain,
15.6% in Italy, 16.2% in France,
17.5% in Denmark and 19.2% in
Greece. The prevalence of
obesity by European country for
women was: 26.9% in Austria,
22.9% in Germany, 21.5% in
Sweden, 23.2% in the
Netherlands, 33.6% in Spain,
23.4% in Italy, 20.3% in France,
18.2% in Sweden and 31.2% in
Greece.
Comparison
between
regions - USA
+ Europe
BMI is corrected for self-report bias
using formula derived from
NHANES study (Cawley &
Burkhauser, 2006)
Avendano,
M100
2009 50-74 y/o Cross sectional data in 2004
comparing three studies:
HRS in USA, ELSA in
England and SHARE in
Europe
WHO cut-
points
Prevalence of obesity: 28.8% in
US, 26.1% in UK and 17.8% in
Europe
Comparison
between
regions - USA
+ Europe
Young, TK29 2007 ≥ 18 y/o Cross sectional study using
4 studies of Inuit people (1
in Alaska, 2 in Canada and
1 in Greenland) conducted
between 1990 and 2001
WHO cut-
points
A total of 15.8% of Inuit men
had obesity while 25.5% of
women had obesity.
Multi-country
study of Inuit
people
No significant differences between
countries were observed
Stewart, ST3 2009 ≥ 18 y/o Uses cross sectional data to
estimate trends in Obesity
and estimate impact on
mortality in 2020
WHO cut-
points
25.2 [1973-1979]; 26.5 [1990];
27.9 [2000]; 28.3 [2005]
North America Forecasts of life expectancy in the
United States for a representative
18-year old assuming trends in
smoking and BMI remain constant.
Project 45% of US population will
be obese by 2020. NHANES

CNPHS = Canadian National Population Health Survey

NHANES = National Health and Nutrition Examination Survey (USA)

ELSA = English Longitudinal Study of Ageing

SHARE = Survey of Health, Ageing and Retirement in Europe

SABE = Health, Well-being and Ageing Survey (Latin America and the Caribbean)

MHAS = Mexican Health and Ageing Study

In the United States, studies using data from the National Health and Nutrition Examination Survey (NHANES) report increasing trends in obesity over time 5-10. Ford and colleagues reported an increase in the prevalence of obesity from 11.1% in the 1970’s to 19.3% in the early 2000’s 9. The most recent data from NHANES report obesity prevalence to be approximately 32% for men and 36% for women 8;10. The difference between men and women is not statistically significant based on the overlapping confidence intervals. Nevertheless, the trend over time has continued to increase for men, while for women it seems to be stabilizing 8;11. Race /ethnic differences are also reported in the increasing obesity trends, with African-Americans having the highest rates, followed by Hispanics 8.

Obesity in Canada is lower. The overall prevalence of obesity in the mid 1990’s was reported at 12.8% 12, half that reported in the USA using data from the NHANES study in a similar time period (Table 1). A steady rise in the obesity trends is observed in Canada as well, with obesity rates of 8.1% for men in the 1970’s increasing to 13.4% in the 1990’s and rates of 12.7% rising to 15.4% in women 13. MacDonald and colleagues, using the cut-off point of 27 kg/m2 for obesity, found obesity rate of 35% for men 27% for women in ten provinces from Canada 14. The lower cut-off point explains the large difference in the prevalence between this and the other Canadian studies (Table 1). Nevertheless, we cannot determine why the prevalence rate is higher in men than in women, in contrast to studies in North America. Ethnic differences are also observed in Canada, with Aboriginals reporting higher rates of obesity 15;16.

The few studies available on prevalence of obesity in Latin America and the Caribbean in older adults also report an increase over time. A large variation between countries is also observed 17-19. Using data from the Health, Well-being and Ageing Survey (SABE), the prevalence of category I obesity (BMI of 30 to < 35 Kg/m2) for men and women combined, ranged between 10.4% in Havana to 22.9% in Santiago; the prevalence of category II and extreme obesity (BMI = 35 Kg/m2) ranged from 2.9% in Havana to 15.7% in Montevideo 17. Thus, obesity of any category ranged between 13.3% and 38.6% in the SABE study (Table 1). The two remaining studies summarized in Table 1 on Latin America, were conducted only in Brazil and Mexico. In Brazil the prevalence of obesity seemed to reach a plateau in the early 2000’s for women,while for men the trend continued to increase 18. The prevalence reported in the single country studies falls in the range reported in the SABE study (Table 1).

In Europe, both cross-sectional and longitudinal studies report a large variation in the prevalence of obesity between countries. Using data from the Europe Action on Secondary and Primary Intervention through Intervention to Reduce Events (EUROASPIRE) surveys, the average prevalence of obesity increased from 25% in EUROASPIRE I to 38% in EUROASPIRE III 20. Studies using data from the Survey of Health, Ageing and Retirement in Europe (SHARE) and the English Longitudinal Study of Ageing (ELSA) reported average prevalence of obesity for men of 16.2% and 17.8% for women 21. Nevertheless the variation observed ranges between 12.8% for men in Sweden to 20.2% for men in Spain, and between 12.3% for women in Switzerland to 21.9% for women in Greece (Table 1). Studies using data from only one country also reported a difference in the prevalence of obesity between men and women and an increasing trend in the prevalence of obesity over time 22-27. In most countries the prevalence of obesity is higher for women (Table 1).

Cross-sectional studies comparing USA to Europe showed that obesity rates in USA were higher for both men and women(Table 1). In 2004, the prevalence of obesity for the USA was reported at 30.7% for men compared to 17.6% in Europe, and 37.9% in women compared to 24.2% respectively 28. A large variability is noted again between obesity rates in the different European countries. However, no country reaches the exceedingly high obesity rates of the USA. One last study examined obesity rates among Inuit people in Canada, Alaska and Greenland and reported no significant differences between countries, with an overall prevalence of obesity of 15.8% for Inuit men and 25.5% for Inuit women 29.

Finally, Stewart and colleagues used data from the NHANES to predict obesity rates in 2020 and estimate its impact on mortality 3. Their projections showed that life expectancy is decreased by almost 1 year in the USA for a representative 18 year-old person, assuming trends in smoking continue to decrease and trends in body mass index (BMI) continue to increase at the same rate observed between 1973 and 2005. Additionally, the projection shows that the overall prevalence of obesity for adults in the USA will be 45% by the year 2020 3.

We did not include Asia or Australia as regions in Table 1 because of the limited number of studies available on the epidemiology of obesity in older adults in these continents. Additionally, a large variability in the prevalence of obesity has been reported in the literature on Asian older adults. However, to include all major regions in the world we analyzed two documents that analyze obesity in Asia and Australia. Based on a report by the WHO, the major difficulty with accurately examining obesity among Asians is the large variation in cultural and economic conditions of Asian populations and the fact that current WHO cut-off points for obesity seem to provide an erroneous estimate based on higher prevalence of adverse events at lower BMI values. This report by the WHO proposes that the cut-off point for obesity among Asian adults should be 25 kg/m2 30.

The WHO report on Asia summarizes some studies that have looked at epidemiology of obesity. Most data on obesity in Asia come from single country studies or from countries where a large portion of the population is of Asian origin, like the island of Mauritius. Obesity trends are rapidly rising in all Asian nations. Obesity rates range between less than 1% in rural populations in countries like China, to around 9% in urban areas of Malaysia. A large variation by gender and ethnicity is observed in several countries including Malaysia and China. In summary, the data from Asian countries reports much lower obesity rates compared to other regions. The WHO however, strongly advocates for a new definition of obesity with different cut-off points based on the trends in obesity rates and the increase in the prevalence of obesity associated complications such as cardiovascular diseases.

In Australia, analysis of trends from cross-sectional surveys conducted since the 1980’s were summarized by the Australian Institute of Health and Welfare in a bulletin published in 2004 31. Similar to what has been reported in other continents, the rates of obesity among older adults has increased over time. Between the 1980’s and the early 2000’s an increase in prevalence of obesity was observed from 11% to 23% in adults over 65 31. The most recent reports show that between 25-30% of adults approaching retirement in Australia are obese.

In summary, obesity has increased noticeably in all continents among older adults. Large variations between countries, race/ethnic groups and genders are observed. Despite these variations, public health implications need to be carefully analyzed and addressed to prevent disability and decreased quality of life for older adults around the world in the near future.

Obesity and Disability

Disability is a broad term that can be defined in many different ways. Lack of a single definition and availability of several validated tools to measure different types of disability make cross-study comparisons on disability difficult. Nevertheless, the ample literature showing that disability increases the risk of mortality and institutionalization and affects quality of life in older age make disability a concept that must be carefully analyzed and better understood 32-35. Conditions that increase the risk of disability are therefore highly important.

Table 2 summarizes relevant studies that analyze the relationship between obesity and disability. Obesity is not measured consistently although all studies use either BMI, waist circumference or body composition to define obesity. Similarly, the definition of disability varies between the different studies. The first studies listed are longitudinal studies. They are consistent in showing that, over time, the presence of obesity increases the risk of becoming disabled 25;36-43. Nevertheless, of the nine longitudinal studies listed, seven studies use Activities of Daily Living (ADL) to define disability 25;36;38;39;41-43. Five of the seven studies use the same six activities (walking across a room, bathing, eating, dressing, toileting and transferring in and out of bed) and define disability as difficulty performing one or more activities 25;36;38;39;43. From these studies we can conclude that obesity is an independent risk factor for developing ADL disability over time. The remaining studies use upper and lower body function and work related disability. Each study concludes that obesity increases the risk of the defined disability 37;40. The studies by Reynolds et al. and Walter et al. also conclude that obesity hampers the probability of recovery from disability in older adults 38;41. In some of the longitudinal studies, the effect of obesity on disability was larger for women compared to men (Table 2).

Table 2.

Summary of literature review of studies analyzing the relationship between obesity and disability

Author Year Age of
participants
Type of
Study
Obesity
measure used
Disability measure used Relationship between obesity
and disability
Notes
Ferraro,
KF37
2002 25-74 y/o Longitudinal
study
BMI with WHO
cut-off points
A total of 19 items from the Stanford
Health Assessment Questionnaire
Disability Index. Nine items were
grouped to measure lower-body
disability and ten items were grouped to
measure upper-body disability.
At baseline, obesity was related to
upper-body disability but not lowerbody
disability. Overtime, both
underweight and obesity were
related to upper and lower-body
disability.
Relationship between
overweight and disability
was not consistent for the
different groups
analyzed.
Visscher,
TL40
2004 Adults 20-92
y/o,
dichotomized
using 65 as
cut-off point
Longitudinal
study
BMI with WHO
cut-off points
Receiving any work disability pension
from the National Social Insurance
Institutions in Finland
Overweight and obesity were
related to higher risk of work
disability.
Risk of work disability
was higher for younger
adults (<65 y/o)
compared to older adults
(>65 y/o). Effect of
obesity on onset of
cardiovascular disease,
long-term medication use
and unhealthy life years
was also assessed.
Sturm, R39 2004 50-69 y/o Longitudinal
study
BMI with WHO
cut-off points
Difficulty with ADL or positive reports of
“impairment or health problem that
limits the kind/amount of paid work.”
The probability of ADL disability
was 50% higher for men with BMI
between 30-35, compared to men
with BMI between 20-25. The
probability increased to 300% if
BMI was > 35. For women the
effect is larger with double the risk
for women with BMI between 30-
35 and four times the risk for
women with BMI >35.
Uses HRS study
Reynolds,
SL38
2005 ≥ 70 y/o Longitudinal
study
BMI using WHO
cut-off point of 30
to create 2
categories
(Obese vs. Non-
obese)
Difficulty in one or more ADL Incidence of disability between
1993 and 1998 was higher for
obese adults compared to non-
obese adults (16.7% vs. 12.7%).
Obese older adults also had
significantly higher probability of
becoming disabled compared to
non-obese adults.
Obesity had little effect
on life expectancy.
Obesity also affected
likelihood of recovering
from disability.
Wilkins,
M42
2005 ≥ 45 y/o Conducts
crosssectional
analysis
using data
from CCHS
in 2003 and
longitudinal
analysis
using data
from the
NPHS
waves 1-4
BMI with WHO
cut-off points
ADL/IADL Dependency in ADL/IADL was
almost the same for older adult
who were underweight and those
with obesity class III.
Controlling for
confounders in stepwise
for at the end of analysis.
Obesity was predictive of
dependency in ADL/IADL
over time.
Al Snih,
S36
2007 ≥ 65 y/o Longitudinal
study
BMI with WHO
cut-off points
Difficulty with one or more ADL A “U” shaped relationship between
BMI and disability was observed.
Disability-free life expectancy was
highest for older adults with BMI
between 25-30.
Used sample with non-
Hispanic Whites, African-
Americans and
Hispanics.
Lang, IA25 2008 ≥ 65 y/o Longitudinal
study
BMI with WHO
cut-off points
Self-reported and measured physical
function was assessed. Self-reported
physical function was assessed through
difficulty in one or more ADL. Measured
physical function was assessed through
the SPPB, a score ≤ 7 was considered
disability.
Rise in poor self-reported and
measured physical function with
increasing BMI. Over time obese
were more likely to develop
disability compared to normal-
weight adults.
Uses ELSA study
Walter, S41 2009 ≥ 55 y/o Longitudinal
study
BMI with WHO
cut-off points and
WC divided in
three categories
for men and
women
separately.
ADL from the HAQ-DI Index. HAQ-DI
score ≥ 0.5 considered disability
Obesity doubles the risk of
disability over time.
BMI also decreases the
probability of recovery
from disability over time.
Al Snih S44 2010 ≥ 65 y/o Cross
sectional
study using
data from
the SABE
study that
included 6
cities in
Latin
America
WHO cut-points,
separates
category I (BMI
between 30 and
34.9) from
category II and
extreme obesity
(BMI ≥ 35)
Difficulty in one or more ADL Obesity is an independent factor
contributing to ADL disability.
Category I and Category II obesity
are presented separately.
Variation by country
observed, however
relationship present in all
countries.
Himes,
CL49
2000 ≥ 70 y/o Cross-
sectional
study
BMI with WHO
cut-off points
Self-reported limitations in one or more
ADL or any difficulty with one or more
items of the Nagi disability scale.
As BMI increase ADL limitations
increase
Effect of obesity on each
ADL was analyzed and
on ADL and Nagi
activities separately.
Effect of obesity on five
medical conditions is also
analyzed.
Pedersen,
AN51
2002 80 y/o Cross-
sectional
study
BMI with 3
categories: <24
kg/m2, 24-29
kg/m2, > 29
kg/m2 and body
fat mass and fat-
free mass
measured with
bioelectrical
impedance.
Measured with muscle strength, physical
activity, functional ability and selfreported
functional ability.
Higher body weight and higher
BMI were correlated with better
muscle strength. Individuals with
BMI < 24 had a tendency of having
higher muscle strength compared
to individuals with BMI > 24,
differences were only statistically
significant for women. There was
no difference in physical activity or
functional ability by BMI group.
Chen, H47 2002 65-92 y/o Cross-
sectional
study
Waist
circumference
divided in
quintiles for men
and women
separately or
BMI with WHO
cut-off points
A 12 item ADL questionnaire adapted
from Katz scale. Score divided in three
categories: 1) no disability, 2) some
disability and 3) considerable disability
Weight change after age 50 had a
“U” shaped relationship with
disability. Abdominal obesity and
weight gain were associated with
greater disability in men and
women. BMI greater than 35 was
associated with greater disability
only among women.
Representative sample of
Hispanics in
Massachusetts. Women
had a higher disability
score compared to men.
Higher proportion of
women compared to men
had obesity. However,
men had a higher
average waist
circumference compared
to women. Women
reported higher average
weight change compared
to men.
Zoico, E50 2004 Women 67-
78 y/o
Cross
sectional
study
BMI with WHO
cut-off points and
fat percentage
measured with
DXA
Combination of 3 scales: ADL, three
Rosow and Breslau functional items and
IADL
Both higher BMI values and higher
fat percentage were associated
with higher prevalence of disability
Woo, J54 2007 ≥ 65 y/o Cross-
sectional
study
BMI using cut-off
point previously
reported for
Asian
populations
Physical activity level determined
through the PASE scale or difficulty
performing one of the following: walking
2-3 blocks, climbing 10 steps, meal
preparation, doing heavy house work
and shopping.
Older adults with category I and
category II obesity (BMI between
25-29.9 kg/m2 and ≥ 30 kg/m2) had
greater number of impairments
performing the different activities.
A “U” shape relationship between
BMI and physical performance is
reported.
Study using men and
women in Hong-Kong.
Additional analyses show
that fat mass associated
with physical function
while apendicular muscle
mass was not.
Alley, DE45 2008 ≥ 60 y/o Cross-
sectional
study using
data to
analyze
disability
trends in
the United
States
BMI with WHO
cut-off points
Two types of disability indicators: 1)
functional limitations 2) ADL
At baseline, prevalence of
functional impairment was lowest
among the normal weight adults
(26.7%) and increased for
overweight adults (27.4%) and
obese adults (36.8%); prevalence
of ADL impairment was 5% for
underweight, 4.3% for overweight
and 6% for obese older adults. At
follow up, the prevalence of
functional impairment was 26.6%
for normal weight adults, 25.8% for
overweight and 42.2% for obese
older adults; prevalence of ADL
impairment was 3.5% in normal
weight, 3% in overweight and 5.5%
in obese.
“J” shaped observed in
the relationship between
obesity and disability
reported in other studies,
for ADL disability at
baseline and follow-up
and for functional
impairment at follow-up.
Over time the prevalence
of functional impairment
increased for obese
individuals, but no
change was observed for
ADL impairment.
Chen, H48 2008 ≥ 60 y/o Cross-
sectional
study
Sex specific
quartiles and
WHO cut-off
points in addition
to waist
circumference
A total of 19 questions to assess the
level of difficulty in performing physical
or mental task without using special
equipment were used to measure
functional status. The items were
classified into five domains: 1) ADL, 2)
IADL, 3) Leisure and social activities, 4)
Lower extremity mobility, 5) general
physical activities. Disability was defined
as with one or more activities within a
given domain.
BMI was positively associated with
all measures of functional disability
in women and with disability in all
domains but ADL and IADL in
men.
Waist circumference also
associated to disability.
Waist circumference is
suggested as a stronger
indicator of disability for
women compared to
men.
Rolland,
Y52
2009 Women 75
y/o or older
Cross-
sectional
study
Percentage body
fat above the
60th percentile
measured with
DXA
Difficulty in 3 or more mobility activities
(walking, climbing stairs, going down
stairs, rising from chair or bed, picking
up object from floor, lifting heavy object
or reaching for objects).
Compared with the group with
normal body composition, obese
women had 44-79% higher odds of
having difficulty with functional
measures.
Association between
obesity, sarcopenia and
their combination with
disability was examined.
Obesity alone and
sarcopenia with obesity
both increase the risk of
disability.
Berraho,
M46
2010 ≥ 65 y/o Cross-
sectional
study
BMI with WHO
cut-off points
Hierarchical index aggregating three
domains of disability into a single
measure: mobility, ADL and IADL.
Individuals were considered dependent
if they could not perform at least one
activity of the domain without help.
The highest proportion of
independent older adults was
among those with a BMI range
between 25-30 kg/m2. The highest
rates of mobility disability were
observed in obese older adults.
Differences observed in
the relationship between
obesity and disability
depending on type of
disability measured.
Vincent,
HK53
2010 ≥ 60 y/o Literature
Review
article with
cross-
sectional
and
longitudinal
studies
BMI, body fat
percentage or fat
mass.
Mobility disability measure with at least
one of the following: walk time, walk
distance, transfers, chair rise to timedup-
and-go test to stair climb.
Cross-sectional studies show that
obesity is associated with poor
lower extremity mobility in older
men and women. Most longitudinal
studies reported that higher
adiposity was related to declining
mobility over time. Walking, stair
climbing, and chair rise were
especially affected if BMI was
greater than 35 kg/m2. Mobility
impairment in older obese adults
was more common for women
compared to men.
A few interventional
studies reviewed provide
evidence that weight loss
is related with better
mobility.
Wee CC43 2011 ≥65 y/o Longitudinal
Study
BMI with WHO
cut-off points
Difficulty with one or more ADL or
Difficulty with one or more IADL
Overweight and obesity were
associated with new or progressive
ADL and IADL disability in a dose-
dependent manner, particularly for
white men and women.
Obesity was not
associated with mortality,
except for those with at
least moderately severe
obesity.

CCHS = Canadian Community Health Survey

NPHS = National Population Health Survey in Canada

ADL = Activities of Daily Living

IADL = Instrumental Activities of Daily Living

DXA = Dual energy X-ray absorptiometry

ELSA = English Longitudinal Study on Ageing

HAQ-DI = Health Assessment Questionnaire Disability Index

Following the longitudinal studies, cross-sectional studies analyzing the relationship between obesity and disability are listed (Table 2). Similar to the longitudinal studies, disability is defined in different ways. Of the 11 cross-sectional studies included, seven use ADL exclusively or in combination with other functionality measures to define disability 44-50. Three studies also use Instrumental Activities of Daily Living (IADL) to define disability 46;48;50. The remaining studies use either physical function or mobility disability to define disability 51-54. All studies conclude that obesity is related to increased disability regardless of how it is measured. Some of the studies analyze the relationship between obesity and muscle strength and suggest that, despite the deleterious effects of obesity on muscle function, additional pathways need to be analyzed to understand the pathophysiology behind the onset of disability in older obese adults 50-54.

Several studies report that the relationship between weight or BMI and disability has a “U” or a “J” shape, meaning that not only obesity but underweight older adults have increased risk of disability 36;45;48. Normal weight and maybe some overweight older adults seem to have the lowest risk of disability of all weight or BMI groups. This has important implications for prevention and treatment schemes, since losing too much weight can be detrimental for older adults as well.

In summary, obesity is related to increased risk of disability among older adult populations. Obesity also seems to affect recovery from disability over time. Obesity not only affects functional status but it also affects mobility. Policy makers and healthcare providers need to keep this relationship in mind, and design obesity prevention and obesity management programmes that can improve functional status in older adults and protect them from becoming disabled, with resultant poor quality of life.

Implications of obesity on chronic diseases

Despite the widely know deleterious effects of obesity on overall health, obesity in older age has to be analyzed with caution. Obesity significantly increases the risk of death among older adults. Never the less, the relationship between BMI and mortality is unique in the older adult population because very low BMI values are related to the highest mortality risk, this risk decreases as BMI increases to normal and overweight values and then mortality risk increases again, with a sharp increase in BMI values greater than 35kg/m2 36;55;56. Additionally, weight loss has been reported as a risk factor for adverse events in some older adults including fractures, falls and mortality 57;58. Despite this, healthcare costs for older obese adults are higher than for older adults with normal weight59;60. Similarly, disability rates and complications from obesity have been widely reported among the older adult population 61-63. We reviewed the literature and have summarized the implications of obesity on different diseases in the older adult population.

Obesity and Cardiovascular disease

Obesity is an independent risk factor for development of heart failure, acute events like myocardial infarctions and stroke in older adults 64;65. Obesity increases the risk of hypertension and affects overall response to anti-hypertensive medications 66-68. A “U” shaped relationship between BMI and hypertension has been reported 69. Two major causes have emerged as explanatory causes for cardiovascular disease resulting from obesity: anatomic and physiologic alterations. Anatomic alterations are explained because obesity affects the architecture and physiology of the cardiovascular system. Obesity causes atrial and ventricular enlargement and plaque formation in the vessels 70-72. These changes not only affect cardiovascular function, but also increase the risk of developing potentially lethal conditions like atrial fibrillation and abdominal aortic aneurysms 73;74.

Obesity triggers metabolic dysregulation and inflammation 50;75;76. Decreased levels of natriuretic peptide, a peptide that protects against acute events like myocardial infarctions, have been reported 68;77. Other physiologic alterations include increased levels of inflammatory markers (interleukin-6, C - reactive protein and tumor necrosis factor) that affect the body’s response to physiologic changes and put an additional burden on the cardiovascular system 76. Increased adiposity enhances insulin resistance and therefore the risk for adverse cardiovascular events overall 50;78.

Obesity, Diabetes and the Metabolic Syndrome

Obesity, diabetes and the metabolic syndrome are closely related. Obesity and diabetes are distinct clinical conditions that occur independently despite sharing some pathophysiologic pathways. The metabolic syndrome is also independent from obesity and diabetes. It is a collection of risk factors that cause damage to the cardiovascular system, increasing the risk of heart attack, stroke and other cardiovascular diseases. Increased body fat and increased blood sugar are two of the eight components of the metabolic syndrome79;80.

Unlike the relationship between obesity and mortality in older adults, the relationship between obesity, diabetes and the metabolic syndrome is very similar in older adults compared to younger adults. A large body of evidence has shown that obesity increases the risk of developing diabetes and the metabolic syndrome 80;81. There is also evidence that obesity, diabetes and the metabolic syndrome are independent risk factors for cardiovascular disease 80. Increased oxidative stress in fatty tissue of obese individuals has been proposed as a pathogenic mechanism leading to the metabolic syndrome 82. Additionally, severity of obesity (determined by National Heart Lung and Blood Institute Task Force categories: class 1, class 2 and class 3) is associated with an increasing trend in risk of development of diabetes and the metabolic syndrome 83. It has been reported that this relationship between obesity, diabetes and the metabolic syndrome is especially important among minority populations in developed countries given the higher rates of obesity compared to other population groups and the higher rates of complications and mortality 79.

Obesity and Cancer

More than 60% of cancers occur over the age of 65 84. In the last decade, findings in cancer epidemiology have highlighted the importance of the relation between obesity and cancer 85. Increased body mass and adiposity have been established as risk factors for the development of cancers that affect a large portion of the older adult population such as colon cancer, breast cancer, and prostate cancer 85. Three hormonal systems have been proposed as causal pathways : insulin and insulin-like growth factor axis, sex steroids and adipokines 85;86. These hormonal systems are altered in obesity; however, their role in the development of cancer is probably different for each cancer site. Additionally, the link between obesity and cancer seem to be different for men and women 85-87.

To date there have been no clinical trials exploring the effect of losing weight, or even maintaining weight, on cancer incidence 85;86. However, there is evidence from observational studies that weight maintenance and controlled weight loss may decrease the risk of developing some types of cancers 88;89. Despite the limited information, it has been shown that obesity increases the risk of delayed cancer diagnosis, complications during cancer treatment and poor outcomes after treatment 90;91.

Obesity and arthritis

A common limitation when addressing arthritis in older adults is the lack of differentiation between the types of arthritis described. The most common types of arthritis affecting older adults are osteoarthritis, rheumatoid arthritis and gout. The pathophysiology, treatment and course of each type of arthritis are very different. However, the negative effect of arthritis on older adults is mostly due to its effect on overall physical and mental health and disability rather than a direct increase in mortality risk 92.

The relationship between obesity and arthritis has not been completely explained. Despite the differences in the most common types of arthritis in older adults, both obesity and arthritis are pro-inflammatory conditions that increases the concentration of cytokines and adipokines as previously reported 93. Additionally, arthritis impairs physical activity, necessary for weight loss, and a cornerstone for self-management of arthritis because it diminishes pain and improves physical function 92;94. Both increased levels of inflammatory markers and decreased physical activity in relation to obesity impede adequate management of arthritis and increase the long term effects of the disease 95. In addition, obesity accelerates the deterioration of joint function in older adults with arthritis and negatively affects some outcomes from surgical interventions 92;95.

Obesity and some Geriatric syndromes

Obesity has been linked to some geriatric syndromes. The pro-inflammatory state caused by obesity has been linked to age related muscle loss or sarcopenia 4;50. Sarcopenia has been shown to increase disability and overall mortality and may explain some of the complications reported in obese older adults 4. Sarcopenia and obesity are independent conditions with separate pathophysiologic pathways. However, older adults with comorbid sarcopenia and obesity have become the centre of several studies. Co-occurrence of sarcopenia and obesity places older adults in a unique state of disease that increases the risk of adverse events and requires special interventions 4;50;52;54. Additionally, the pro-inflammatory state has also been related to vascular dysfunction in the brain that increases the production of beta-amyloid, a key component of senile plaques that accumulate in the brain in Alzheimer’s disease 96-98.

In summary, the pro-inflammatory state caused by obesity, in addition to the limitations in physical function, are common links to the added burden of disease when obesity is present concomitantly with many chronic conditions in older adults. Additionally, obesity is a marker of poor outcomes for most interventions for chronic conditions and interferes with management of most chronic diseases in older adults.

Conclusions

Obesity among older adults has increased noticeably in the last two decades in all continents. However, large variations between countries, race/ethnic groups and genders are observed. Obesity is related to increased risk of disability among older adult populations regardless of the measures used. Obesity affects functional status and mobility. Inflammation caused by obesity is linked to the added burden of disease when obesity is present concomitantly with many chronic conditions in older adults. Additionally, it is a marker of poor outcomes for most interventions for chronic conditions and interferes with management of most chronic diseases in older adults.

Policy makers and healthcare providers need to keep obesity-related health outcomes in mind and design obesity prevention and management programmes that can improve functional status in older adults and protect them from becoming disabled with resultant poor quality of life.

Acknowledgment

This study was supported by grants R03-AG029959, R01-AG017638, and R01-AG010939 from the National Institute on Aging, U.S. Dr. Al Snih is supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women’s Health Program–BIRCWH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; the National Institute of Allergy and Infectious Diseases; and the Office of the Director, National Institutes of Health.

Footnotes

Conflict of interest The authors have nothing to disclose.

REFERENCES

  • 1.WHO Obesity and Overweight. 2011 Report No.: 311.
  • 2.Neovius K, Rasmussen F, Sundstrom J, Neovius M. Forecast of future premature mortality as a result of trends in obesity and smoking: nationwide cohort simulation study. Eur J Epidemiol. 2010 Oct;25(10):703–9. doi: 10.1007/s10654-010-9485-x. [DOI] [PubMed] [Google Scholar]
  • 3.Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009 Dec 3;361(23):2252–60. doi: 10.1056/NEJMsa0900459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di F, V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 2005 Sep;29(9):1011–29. doi: 10.1038/sj.ijo.0803005. [DOI] [PubMed] [Google Scholar]
  • 5.Bleich SN, Wang YC, Wang Y, Gortmaker SL. Increasing consumption of sugar-sweetened beverages among US adults: 1988-1994 to 1999-2004. Am J Clin Nutr. 2009 Jan;89(1):372–81. doi: 10.3945/ajcn.2008.26883. [DOI] [PubMed] [Google Scholar]
  • 6.Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, Crouse JR, et al. 30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006. Am J Cardiol. 2010 Oct 1;106(7):969–75. doi: 10.1016/j.amjcard.2010.05.030. [DOI] [PubMed] [Google Scholar]
  • 7.Crimmins EM, Alley D, Reynolds SL, Johnston M, Karlamangla A, Seeman T. Changes in biological markers of health: older Americans in the 1990s. J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1409–13. doi: 10.1093/gerona/60.11.1409. [DOI] [PubMed] [Google Scholar]
  • 8.Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010 Jan 20;303(3):235–41. doi: 10.1001/jama.2009.2014. [DOI] [PubMed] [Google Scholar]
  • 9.Ford ES, Li C, Zhao G, Pearson WS, Capewell S. Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation. 2009 Sep 29;120(13):1181–8. doi: 10.1161/CIRCULATIONAHA.108.835728. [DOI] [PubMed] [Google Scholar]
  • 10.Ford ES, Li C, Zhao G, Tsai J. Trends in obesity and abdominal obesity among adults in the United States from 1999-2008. Int J Obes (Lond) 2011 May;35(5):736–43. doi: 10.1038/ijo.2010.186. [DOI] [PubMed] [Google Scholar]
  • 11.Stenholm S, Simonsick EM, Ferrucci L. Secular trends in body weight in older men born between 1877 and 1941: the Baltimore Longitudinal Study of Ageing. J Gerontol A Biol Sci Med Sci. 2010 Jan;65(1):105–10. doi: 10.1093/gerona/glp178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kaplan MS, Huguet N, Newsom JT, McFarland BH, Lindsay J. Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian National Population Health Survey. J Gerontol A Biol Sci Med Sci. 2003 Nov;58(11):1018–30. doi: 10.1093/gerona/58.11.m1018. [DOI] [PubMed] [Google Scholar]
  • 13.Torrance GM, Hooper MD, Reeder BA. Trends in overweight and obesity among adults in Canada (1970-1992): evidence from national surveys using measured height and weight. Int J Obes Relat Metab Disord. 2002 Jun;26(6):797–804. doi: 10.1038/sj.ijo.0801991. [DOI] [PubMed] [Google Scholar]
  • 14.Macdonald SM, Reeder BA, Chen Y, Despres JP. Obesity in Canada: a descriptive analysis. Canadian Heart Health Surveys Research Group. CMAJ. 1997 Jul 1;157(Suppl 1):S3–S9. [PubMed] [Google Scholar]
  • 15.Bruce SG, Riediger ND, Zacharias JM, Young TK. Obesity and obesity-related comorbidities in a Canadian First Nation population. Chronic Dis Can. 2010 Dec;31(1):27–32. [PubMed] [Google Scholar]
  • 16.Lix LM, Bruce S, Sarkar J, Young TK. Risk factors and chronic conditions among Aboriginal and non-Aboriginal populations. Health Rep. 2009 Dec;20(4):21–9. [PubMed] [Google Scholar]
  • 17.Al Snih S, Ray L, Markides KS. Prevalence of self-reported arthritis among elders from Latin America and the Caribbean and among Mexican Americans from the southwestern United States. J Ageing Health. 2006 Apr;18(2):207–23. doi: 10.1177/0898264305285661. [DOI] [PubMed] [Google Scholar]
  • 18.Monteiro CA, Conde WL, Popkin BM. Income-specific trends in obesity in Brazil: 1975-2003. Am J Public Health. 2007 Oct;97(10):1808–12. doi: 10.2105/AJPH.2006.099630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ruiz-Arregui L, Castillo-Martinez L, Orea-Tejeda A, Mejia-Arango S, Miguel-Jaimes A. Prevalence of self-reported overweight-obesity and its association with socioeconomic and health factors among older Mexican adults. Salud Publica Mex. 2007;49(Suppl 4):S482–S487. doi: 10.1590/s0036-36342007001000007. [DOI] [PubMed] [Google Scholar]
  • 20.Kotseva K, Wood D, De BG, De BD, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009 Mar 14;373(9667):929–40. doi: 10.1016/S0140-6736(09)60330-5. [DOI] [PubMed] [Google Scholar]
  • 21.Andreyeva T, Michaud PC, van SA. Obesity and health in Europeans aged 50 years and older. Public Health. 2007 Jul;121(7):497–509. doi: 10.1016/j.puhe.2006.11.016. [DOI] [PubMed] [Google Scholar]
  • 22.Charles MA, Eschwege E, Basdevant A. Monitoring the obesity epidemic in France: the Obepi surveys 1997-2006. Obesity (Silver Spring) 2008 Sep;16(9):2182–6. doi: 10.1038/oby.2008.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dugravot A, Sabia S, Stringhini S, Kivimaki M, Westerlund H, Vahtera J, et al. Do socioeconomic factors shape weight and obesity trajectories over the transition from midlife to old age? Results from the French GAZEL cohort study. Am J Clin Nutr. 2010 Jul;92(1):16–23. doi: 10.3945/ajcn.2010.29223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci. 2010 Apr;65(4):377–81. doi: 10.1093/gerona/glp186. [DOI] [PubMed] [Google Scholar]
  • 25.Lang IA, Llewellyn DJ, Alexander K, Melzer D. Obesity, physical function, and mortality in older adults. J Am Geriatr Soc. 2008 Aug;56(8):1474–8. doi: 10.1111/j.1532-5415.2008.01813.x. [DOI] [PubMed] [Google Scholar]
  • 26.Morabia A, Costanza MC. The obesity epidemic as harbinger of a metabolic disorder epidemic: trends in overweight, hypercholesterolemia, and diabetes treatment in Geneva, Switzerland, 1993-2003. Am J Public Health. 2005 Apr;95(4):632–5. doi: 10.2105/2004.047877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gomez-Cabello A, Pedrero-Chamizo R, Olivares PR, Luzardo L, Juez-Bengoechea A, Mata E, et al. Prevalence of overweight and obesity in non-institutionalized people aged 65 or over from Spain: the elderly EXERNET multi-centre study. Obes Rev. 2011 Apr 27; doi: 10.1111/j.1467-789X.2011.00878.x. [DOI] [PubMed] [Google Scholar]
  • 28.Michaud PC, van Soest A, Andreyeva T. Research Paper. SEDAP; 2007. Cross-country varaition in obesity patterns among older Americans and Europeans. Report No.: 185. [Google Scholar]
  • 29.Young TK, Bjerregaard P, Dewailly E, Risica PM, Jorgensen ME, Ebbesson SE. Prevalence of obesity and its metabolic correlates among the circumpolar inuit in 3 countries. Am J Public Health. 2007 Apr;97(4):691–5. doi: 10.2105/AJPH.2005.080614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.WHO . The Asia-Pacific perspective: Redefining obesity and its treatment. Health Communications Australia; 2001. [Google Scholar]
  • 31.AIHW. Bennet SA, Magnus P, Gibson D. Obesity trends in older Australians. Australian Institute of Health and Welfare; Canberra: 2004. Report No.: 12. [Google Scholar]
  • 32.Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255–63. doi: 10.1093/gerona/59.3.m255. [DOI] [PubMed] [Google Scholar]
  • 33.Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar;49(2):M85–M94. doi: 10.1093/geronj/49.2.m85. [DOI] [PubMed] [Google Scholar]
  • 34.Terry DF, Sebastiani P, Andersen SL, Perls TT. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med. 2008 Feb 11;168(3):277–83. doi: 10.1001/archinternmed.2007.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Verbrugge LM, Reoma JM, Gruber-Baldini AL. Short-term dynamics of disability and well-being. J Health Soc Behav. 1994 Jun;35(2):97–117. [PubMed] [Google Scholar]
  • 36.Al Snih S, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS. The effect of obesity on disability vs mortality in older Americans. Arch Intern Med. 2007 Apr 23;167(8):774–80. doi: 10.1001/archinte.167.8.774. [DOI] [PubMed] [Google Scholar]
  • 37.Ferraro KF, Su YP, Gretebeck RJ, Black DR, Badylak SF. Body mass index and disability in adulthood: a 20-year panel study. Am J Public Health. 2002 May;92(5):834–40. doi: 10.2105/ajph.92.5.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Reynolds SL, Saito Y, Crimmins EM. The impact of obesity on active life expectancy in older American men and women. Gerontologist. 2005 Aug;45(4):438–44. doi: 10.1093/geront/45.4.438. [DOI] [PubMed] [Google Scholar]
  • 39.Sturm R, Ringel JS, Andreyeva T. Increasing obesity rates and disability trends. Health Aff (Millwood ) 2004 Mar;23(2):199–205. doi: 10.1377/hlthaff.23.2.199. [DOI] [PubMed] [Google Scholar]
  • 40.Visscher TL, Rissanen A, Seidell JC, Heliovaara M, Knekt P, Reunanen A, et al. Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med. 2004 Jul 12;164(13):1413–20. doi: 10.1001/archinte.164.13.1413. [DOI] [PubMed] [Google Scholar]
  • 41.Walter S, Kunst A, Mackenbach J, Hofman A, Tiemeier H. Mortality and disability: the effect of overweight and obesity. Int J Obes (Lond) 2009 Dec;33(12):1410–8. doi: 10.1038/ijo.2009.176. [DOI] [PubMed] [Google Scholar]
  • 42.Wilkins K, de Groh M. Body mass and dependency. Health Reports. 2005;17(1):27–39. [PubMed] [Google Scholar]
  • 43.Wee CC, Huskey KW, Ngo LH, Fowler-Brown A, Leveille SG, Mittlemen MA, et al. Obesity, race, and risk for death or functional decline among medicare beneficiaries: a cohort study. Ann Intern Med. 2011 May 17;154(10):645–55. doi: 10.7326/0003-4819-154-10-201105170-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Al Snih S, Graham JE, Kuo YF, Goodwin JS, Markides KS, Ottenbacher KJ. Obesity and disability: relation among older adults living in Latin America and the Caribbean. Am J Epidemiol. 2010 Jun 15;171(12):1282–8. doi: 10.1093/aje/kwq087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Alley DE, Chang VW. The changing relationship of obesity and disability, 1988-2004. JAMA. 2007 Nov 7;298(17):2020–7. doi: 10.1001/jama.298.17.2020. [DOI] [PubMed] [Google Scholar]
  • 46.Berraho M, Nejjari C, Raherison C, El AY, Tachfouti N, Serhier Z, et al. Body mass index, disability, and 13-year mortality in older French adults. J Ageing Health. 2010 Feb;22(1):68–83. doi: 10.1177/0898264309349422. [DOI] [PubMed] [Google Scholar]
  • 47.Chen H, Bermudez OI, Tucker KL. Waist circumference and weight change are associated with disability among elderly Hispanics. J Gerontol A Biol Sci Med Sci. 2002 Jan;57(1):M19–M25. doi: 10.1093/gerona/57.1.m19. [DOI] [PubMed] [Google Scholar]
  • 48.Chen H, Guo X. Obesity and functional disability in elderly Americans. J Am Geriatr Soc. 2008 Apr;56(4):689–94. doi: 10.1111/j.1532-5415.2007.01624.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Himes CL. Obesity, disease, and functional limitation in later life. Demography. 2000 Feb;37(1):73–82. [PubMed] [Google Scholar]
  • 50.Zoico E, Di F, V, Guralnik JM, Mazzali G, Bortolani A, Guariento S, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord. 2004 Feb;28(2):234–41. doi: 10.1038/sj.ijo.0802552. [DOI] [PubMed] [Google Scholar]
  • 51.Pedersen AN, Ovesen L, Schroll M, Avlund K, Era P. Body composition of 80-years old men and women and its relation to muscle strength, physical activity and functional ability. J Nutr Health Ageing. 2002;6(6):413–20. [PubMed] [Google Scholar]
  • 52.Rolland Y, Lauwers-Cances V, Cristini C, Van KG Abellan, Janssen I, Morley JE, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr. 2009 Jun;89(6):1895–900. doi: 10.3945/ajcn.2008.26950. [DOI] [PubMed] [Google Scholar]
  • 53.Vincent HK, Vincent KR, Lamb KM. Obesity and mobility disability in the older adult. Obes Rev. 2010 Aug;11(8):568–79. doi: 10.1111/j.1467-789X.2009.00703.x. [DOI] [PubMed] [Google Scholar]
  • 54.Woo J, Leung J, Kwok T. BMI, body composition, and physical functioning in older adults. Obesity (Silver Spring) 2007 Jul;15(7):1886–94. doi: 10.1038/oby.2007.223. [DOI] [PubMed] [Google Scholar]
  • 55.Auyeung TW, Lee JS, Leung J, Kwok T, Leung PC, Woo J. Survival in older men may benefit from being slightly overweight and centrally obese--a 5-year follow-up study in 4,000 older adults using DXA. J Gerontol A Biol Sci Med Sci. 2010 Jan;65(1):99–104. doi: 10.1093/gerona/glp099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kapoor JR, Heidenreich PA. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J. 2010 Jan;159(1):75–80. doi: 10.1016/j.ahj.2009.10.026. [DOI] [PubMed] [Google Scholar]
  • 57.Amador LF, Al SS, Markides KS, Goodwin JS. Weight change and mortality among older Mexican Americans. Ageing Clin Exp Res. 2006 Jun;18(3):196–204. doi: 10.1007/BF03324649. [DOI] [PubMed] [Google Scholar]
  • 58.Locher JL, Roth DL, Ritchie CS, Cox K, Sawyer P, Bodner EV, et al. Body mass index, weight loss, and mortality in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2007 Dec;62(12):1389–92. doi: 10.1093/gerona/62.12.1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Daviglus ML, Liu K, Yan LL, Pirzada A, Manheim L, Manning W, et al. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA. 2004 Dec 8;292(22):2743–9. doi: 10.1001/jama.292.22.2743. [DOI] [PubMed] [Google Scholar]
  • 60.Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med. 2004 Oct 25;164(19):2135–40. doi: 10.1001/archinte.164.19.2135. [DOI] [PubMed] [Google Scholar]
  • 61.Nafiu OO, Kheterpal S, Moulding R, Picton P, Tremper KK, Campbell DA, Jr., et al. The association of body mass index to postoperative outcomes in elderly vascular surgery patients: a reverse J-curve phenomenon. Anesth Analg. 2011 Jan;112(1):23–9. doi: 10.1213/ANE.0b013e3181fcc51a. [DOI] [PubMed] [Google Scholar]
  • 62.Schafer MH, Ferraro KF. Long-term obesity and avoidable hospitalization among younger, middle-aged, and older adults. Arch Intern Med. 2007 Nov 12;167(20):2220–5. doi: 10.1001/archinte.167.20.2220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation. 2005 Nov 22;112(21):3247–55. doi: 10.1161/CIRCULATIONAHA.105.553743. [DOI] [PubMed] [Google Scholar]
  • 64.Caterson ID, Hubbard V, Bray GA, Grunstein R, Hansen BC, Hong Y, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. Circulation. 2004 Nov 2;110(18):e476–e483. doi: 10.1161/01.CIR.0000140114.83145.59. [DOI] [PubMed] [Google Scholar]
  • 65.Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002 Dec 9;162(22):2557–62. doi: 10.1001/archinte.162.22.2557. [DOI] [PubMed] [Google Scholar]
  • 66.Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med. 2004 Jun 15;140(12):992–1000. doi: 10.7326/0003-4819-140-12-200406150-00008. [DOI] [PubMed] [Google Scholar]
  • 67.Kaplan NM. Resistant hypertension: what to do after trying ‘the usual’. Geriatrics. 1995 May;50(5):24–30. [PubMed] [Google Scholar]
  • 68.Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004 Feb 10;109(5):594–600. doi: 10.1161/01.CIR.0000112582.16683.EA. [DOI] [PubMed] [Google Scholar]
  • 69.Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007 Oct;120(10):863–70. doi: 10.1016/j.amjmed.2007.05.011. [DOI] [PubMed] [Google Scholar]
  • 70.Al SJ, Higano ST, Hamasaki S, Holmes DR, Lerman A. Association between obesity and coronary atherosclerosis and vascular remodeling. Am J Cardiol. 2001 Dec 1;88(11):1300–3. doi: 10.1016/s0002-9149(01)02093-8. [DOI] [PubMed] [Google Scholar]
  • 71.Al SJ, Higano ST, Holmes DR, Jr., Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001 May;37(6):1523–8. doi: 10.1016/s0735-1097(01)01212-8. [DOI] [PubMed] [Google Scholar]
  • 72.Russo C, Jin Z, Homma S, Rundek T, Elkind MS, Sacco RL, et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol. 2011 Mar 22;57(12):1368–74. doi: 10.1016/j.jacc.2010.10.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006 Nov 27;166(21):2322–8. doi: 10.1001/archinte.166.21.2322. [DOI] [PubMed] [Google Scholar]
  • 74.Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study. Circulation. 2007 Nov 13;116(20):2275–9. doi: 10.1161/CIRCULATIONAHA.107.717926. [DOI] [PubMed] [Google Scholar]
  • 75.Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008 May 6;51(18):1775–83. doi: 10.1016/j.jacc.2007.12.048. [DOI] [PubMed] [Google Scholar]
  • 76.Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007 Apr;56(4):1010–3. doi: 10.2337/db06-1656. [DOI] [PubMed] [Google Scholar]
  • 77.Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, Buffet P, et al. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Heart. 2011 Apr;97(7):551–6. doi: 10.1136/hrt.2010.213041. [DOI] [PubMed] [Google Scholar]
  • 78.Karter AJ, Mayer-Davis EJ, Selby JV, D’Agostino RB, Jr., Haffner SM, Sholinsky P, et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes. 1996 Nov;45(11):1547–55. doi: 10.2337/diab.45.11.1547. [DOI] [PubMed] [Google Scholar]
  • 79.Smith SC, Jr., Clark LT, Cooper RS, Daniels SR, Kumanyika SK, Ofili E, et al. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation. 2005 Mar 15;111(10):e134–e139. doi: 10.1161/01.CIR.0000157743.54710.04. [DOI] [PubMed] [Google Scholar]
  • 80.Vega GL. Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J. 2001 Dec;142(6):1108–16. doi: 10.1067/mhj.2001.119790. [DOI] [PubMed] [Google Scholar]
  • 81.Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005 Apr 11;165(7):777–83. doi: 10.1001/archinte.165.7.777. [DOI] [PubMed] [Google Scholar]
  • 82.Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004 Dec;114(12):1752–61. doi: 10.1172/JCI21625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Ruland S, Hung E, Richardson D, Misra S, Gorelick PB. Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS. Arch Neurol. 2005 Mar;62(3):386–90. doi: 10.1001/archneur.62.3.386. [DOI] [PubMed] [Google Scholar]
  • 84.ASCO . Cancer in older adults. AMerican Society of Clinical Oncology; 2010. [Google Scholar]
  • 85.Renehan AG. Epidemiology of overweight/obesity and cancer risk. In: McTiernan A, editor. Physical activity, dietary calorie restriction and cancer. Springer; New York: 2010. pp. 5–23. [Google Scholar]
  • 86.Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008 Feb;114(1):71–83. doi: 10.1080/13813450801954303. [DOI] [PubMed] [Google Scholar]
  • 87.Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008 Sep;32(9):1431–7. doi: 10.1038/ijo.2008.102. [DOI] [PubMed] [Google Scholar]
  • 88.Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut. 2006 Feb;55(2):285–91. doi: 10.1136/gut.2005.073163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.NCI Obesity and cancer: questions and answers. 2004.
  • 90.Renehan AG, Soerjomataram I, Leitzmann MF. Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe. Eur J Cancer. 2010 Sep;46(14):2581–92. doi: 10.1016/j.ejca.2010.07.052. [DOI] [PubMed] [Google Scholar]
  • 91.Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301–16. doi: 10.1146/annurev.med.080708.082713. [DOI] [PubMed] [Google Scholar]
  • 92.Reynolds SL, McIlvane JM. The impact of obesity and arthritis on active life expectancy in older Americans. Obesity (Silver Spring) 2009 Feb;17(2):363–9. doi: 10.1038/oby.2008.534. [DOI] [PubMed] [Google Scholar]
  • 93.Gomez R, Lago F, Gomez-Reino J, Dieguez C, Gualillo O. Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. J Mol Endocrinol. 2009 Jul;43(1):11–8. doi: 10.1677/JME-08-0131. [DOI] [PubMed] [Google Scholar]
  • 94.Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Kitas GD. Obesity in rheumatoid arthritis. Rheumatology (Oxford) 2011 Mar;50(3):450–62. doi: 10.1093/rheumatology/keq266. [DOI] [PubMed] [Google Scholar]
  • 95.Toivanen AT, Heliovaara M, Impivaara O, Arokoski JP, Knekt P, Lauren H, et al. Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis--a population-based study with a follow-up of 22 years. Rheumatology (Oxford) 2010 Feb;49(2):308–14. doi: 10.1093/rheumatology/kep388. [DOI] [PubMed] [Google Scholar]
  • 96.Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol. 2009 Mar;66(3):300–5. doi: 10.1001/archneurol.2009.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Kingwell K. Dementia: Overweight or obesity during midlife is associated with late-life dementia. Nat Rev Neurol. 2011;7(6):299. doi: 10.1038/nrneurol.2011.74. [DOI] [PubMed] [Google Scholar]
  • 98.Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology. 2011 May 3;76(18):1568–74. doi: 10.1212/WNL.0b013e3182190d09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA. 2006 May 3;295(17):2037–45. doi: 10.1001/jama.295.17.2037. [DOI] [PubMed] [Google Scholar]
  • 100.Avendano M, Glymour MM, Banks J, Mackenbach JP. Health disadvantage in US adults aged 50 to 74 years: a comparison of the health of rich and poor Americans with that of Europeans. Am J Public Health. 2009 Mar;99(3):540–8. doi: 10.2105/AJPH.2008.139469. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES